Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment

European Society for Blood and Marrow Transplantation (EBMT) hematologic response categories comprehensively assess complement inhibitor responses in patients with paroxysmal nocturnal hemoglobinuria (PNH). Using data from the 16-week randomized controlled period of the phase 3 PEGASUS trial (N = 80...

Descripción completa

Detalles Bibliográficos
Autores principales: Fishman, Jesse, Anderson, Seri, Talbird, Sandra E., Dingli, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594490/
https://www.ncbi.nlm.nih.gov/pubmed/37873795
http://dx.doi.org/10.3390/hematolrep15040060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594490/
https://www.ncbi.nlm.nih.gov/pubmed/37873795
http://dx.doi.org/10.3390/hematolrep15040060

Ejemplares similares